Tendyne Holdings, INC.
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$3.7Mgeneral payments (2019-2025)
$0.00research payments (2019-2025)
8clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Gregory Pearl | Dallas, TX | Vascular Surgery | $2,288,842.00 |
| Eduardo De Marchena | Miami, FL | Interventional Cardiology | $489,069.38 |
| Lucian Lozonschi | Tampa, FL | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $343,049.73 |
| Joseph Smith | Rancho Santa Fe, CA | Internal Medicine | $307,078.27 |
| Jeff Burg | Murray, UT | Pediatric Dentistry | $166,334.06 |
| Isaac George | New York, NY | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $39,369.00 |
| William Oneill | Naples, FL | Cardiovascular Disease | $19,684.50 |
| Tomas Salerno | Miami, FL | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $15,747.60 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.